期刊
ARCHIVES OF INTERNAL MEDICINE
卷 162, 期 10, 页码 1190-1192出版社
AMER MEDICAL ASSOC
DOI: 10.1001/archinte.162.10.1190
关键词
-
Allopurinol, a xanthine oxidase inhibitor, has been in use since 1963 as an effective treatment to lower uric acid levels in patients with gout.(1) Severe and occasionally fatal adverse reactions have been attributed to allopurinol use in I of 260 patients and include agranulocytosis, granulomatous hepatitis, and a systemic hypersensitivity syndrome known as the allopurinol hypersensitivity syndrome (AHS),(2) which most frequently develops within days to weeks after initiating allopurinol therapy.(3) The syndrome initially manifests with a rash, ranging from an intensely pruritic maculopapular rash to toxic epidermal necrolysis.(3) Associated with rash are fever, leukocytosis, eosinophilia, evidence of acute hepatic injury, and renal dysfunction.(1,3,4) We describe for the first time a patient with AHS who, along with having the common features of AHS, developed concurrent elevations in pancreatic exocrine enzyme level and new-onset type 1 diabetes mellitus.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据